Research Funded Project
PRE-CLINICAL DEVELOPMENT OF INNOVATIVE NEUROPROTECTIVE & NEUROREGENERATIVE SYNTHETIC MICRO-NEUROTROPHINS FOR THE TREATMENT OF ALZHEIMER DISEASE (DINNESMIN)
Funding Organization: National/ESPA
Contract no.: Τ1ΕΔΚ-03186
Partners: QUALIA PHARMA; BIONATURE E.A. Ltd; FORTH / IMBB; Univ. of CRETE; NATIONAL HELLENIC RESEARCH FOUNDATION; FORTH / ICE-HT;
Duration: From: 2018 - to: 2022
Total Budget: 245.000 EURO
ICE-HT Budget: 99.8750 EURO
Researchers: Antimisiaris, S. (PI)
Type: national
Contract no.: Τ1ΕΔΚ-03186
Partners: QUALIA PHARMA; BIONATURE E.A. Ltd; FORTH / IMBB; Univ. of CRETE; NATIONAL HELLENIC RESEARCH FOUNDATION; FORTH / ICE-HT;
Duration: From: 2018 - to: 2022
Total Budget: 245.000 EURO
ICE-HT Budget: 99.8750 EURO
Researchers: Antimisiaris, S. (PI)
Type: national